$16.54
Price
$836M
Market Cap
—
P/E Ratio
-8.1
Forward P/E
$-3.94
EPS (TTM)
—
Dividend Yield
$309M
Cash
$6M
Total Debt
51M
Shares Out
$8.49
$19.00
52-Week Range
Institutional Ownership of KALA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for KALA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for KALA PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $811K
0
Buys
11
Sells
-811K
Net
0
Grants
Largest
$147K
Palleiko
$120K
Palleiko
$116K
Palleiko
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 08, 2025 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | SELL | 7.3K | $16.51 | $120K |
| Nov 24, 2025 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | SELL | 10.9K | $13.45 | $147K |
| Nov 24, 2025 | Nicole Sweeny | Chief Commercial Officer | SELL | 3.8K | $13.45 | $51K |
| Nov 24, 2025 | Paul K. Audhya | CHIEF MEDICAL OFFICER | SELL | 5.3K | $13.45 | $71K |
| Nov 24, 2025 | Brian Piekos | Chief Financial Officer | SELL | 4.5K | $13.45 | $60K |
| Nov 24, 2025 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | SELL | 4.3K | $13.45 | $58K |
| Nov 20, 2025 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | EXERCISE | 87.4K | $0.00 | $376 |
| Nov 18, 2025 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | SELL | 2.7K | $14.48 | $39K |
| Nov 18, 2025 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | SELL | 4.5K | $14.48 | $65K |
| Nov 18, 2025 | Paul K. Audhya | CHIEF MEDICAL OFFICER | SELL | 3.1K | $14.48 | $45K |
| Nov 12, 2025 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | SELL | 3.3K | $11.55 | $38K |
| Sep 08, 2025 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | SELL | 7.3K | $15.84 | $116K |